Start with a forward-thinking approach to evidence and value.
In today's competitive therapeutic, diagnostic and medical device landscape, companies need to understand product value early on, and develop evidence to demonstrate value to all stakeholders. Market Access Consulting and Health Economics and Outcomes Research (HEOR) are more relevant than ever. Real-world evidence, patient-centered data and economic data are increasingly important to assist regulators and other stakeholders in understanding a product's benefits, risks and value.
Whether you are in Phase I or looking ahead to late phase and post-approval studies, we can work with you to develop and execute strategies tailored to your product's unique value. Our Market Access and HEOR consultants span a variety of scientific and commercially focused disciplines, including epidemiology, real-world evidence, health economics, outcomes research, patient-centered assessment, biostatistics, reimbursement, access strategy and value demonstration.
With our market access and HEOR expertise, we identify evidence gaps and design and execute custom projects to support your product and stakeholder needs. Rely on us to help ensure you are equipped to demonstrate the full value of your product across the audiences of regulators, providers, payers, policymakers and patients.